File S1 - Acid Sphingomyelinase Serum Activity Predicts Mortality in Intensive Care Unit Patients after Systemic Inflammation: A Prospective Cohort Study

Table S1, Procalcitonin (ng/ml) values of the included patients, sorted by survivors and non-survivors. Time points were the day before the PCT peak (PCTbefore), the day of the PCT peak (PCTpeak) and again lowered PCT (PCTlow). Table S2, Acid sphingomyelinase (pMol/ml*h) values for the included patients, sorted by survivors and non-survivors. Time points were the day before the PCT peak (PCTbefore), the day of the PCT peak (PCTpeak) and again lowered PCT (PCTlow). Table S3, C-reactive protein (mg/L) values of the included patients, sorted by survivors and non-survivors. Time points were the day before the PCT peak (PCTbefore), the day of the PCT peak (PCTpeak) and again lowered PCT (PCTlow). Table S4, Lactate (mMol/L) values of the included patients, sorted by survivors and non-survivors. Time points were the day before the PCT peak (PCTbefore), the day of the PCT peak (PCTpeak) and again lowered PCT (PCTlow). Table S5, Modified SOFA-Score (points) values of the included patients, sorted by survivors and non-survivors. Time points were the day before the PCT peak (PCTbefore), the day of the PCT peak (PCTpeak) and again lowered PCT (PCTlow). Table S6, SAPS-Score (points) values of the included patients, sorted by survivors and non-survivors. Time points were the day before the PCT peak (PCTbefore), the day of the PCT peak (PCTpeak) and again lowered PCT (PCTlow). Table S7, TISS-Score (points) values of the included patients, sorted by survivors and non-survivors. Time points were the day before the PCT peak (PCTbefore), the day of the PCT peak (PCTpeak) and again lowered PCT (PCTlow). Table S8, Acid sphingomyelinase activity, Procalcitonin (PCT), C-reactive protein (CRP), Lactate, modified SOFA-Score (mSofa), SAPS II Score and TISS Score of the included patients on the day of intensive care unit (ICU) admission. Table S9, Patients’ characteristics and outcomes of the included patients. Table S10, Patients’ characteristics and outcomes of included patients with systemic inflammatory response syndrome (SIRS) plus Procalcitonin (PCT) peak. Table S11, Patients’ characteristics and outcomes of included patients without systemic inflammatory response syndrome (SIRS) plus Procalcitonin (PCT) peak.
(PDF)